CureVac N.V. Statistics
Share Statistics
CureVac N.V. has 224.31M shares outstanding. The number of shares has increased by 0.19% in one year.
Shares Outstanding | 224.31M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | n/a |
Shares Floating | 93.63M |
Failed to Deliver (FTD) Shares | 1.75K |
FTD / Avg. Volume | 0.36% |
Short Selling Information
The latest short interest is 4.56M, so 2.03% of the outstanding shares have been sold short.
Short Interest | 4.56M |
Short % of Shares Out | 2.03% |
Short % of Float | 4.87% |
Short Ratio (days to cover) | 12.68 |
Valuation Ratios
The PE ratio is -3.23 and the forward PE ratio is -6.55.
PE Ratio | -3.23 |
Forward PE | -6.55 |
PS Ratio | 15.62 |
Forward PS | 11.1 |
PB Ratio | 1.62 |
P/FCF Ratio | -2.6 |
PEG Ratio | n/a |
Enterprise Valuation
CureVac N.V. has an Enterprise Value (EV) of 480.18M.
EV / Earnings | -1.85 |
EV / Sales | 8.93 |
EV / EBITDA | -2.05 |
EV / EBIT | -1.75 |
EV / FCF | -1.49 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.
Current Ratio | 2.57 |
Quick Ratio | 2.43 |
Debt / Equity | 0 |
Total Debt / Capitalization | 0 |
Cash Flow / Debt | 0 |
Interest Coverage | -109.99 |
Financial Efficiency
Return on equity (ROE) is -0.5% and return on capital (ROIC) is -49.11%.
Return on Equity (ROE) | -0.5% |
Return on Assets (ROA) | -0.33% |
Return on Capital (ROIC) | -49.11% |
Revenue Per Employee | 53.81K |
Profits Per Employee | -260.43K |
Employee Count | 999 |
Asset Turnover | 0.07 |
Inventory Turnover | 5.01 |
Taxes
Income Tax | 198.00K |
Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -48.53% in the last 52 weeks. The beta is 2.61, so CureVac N.V.'s price volatility has been higher than the market average.
Beta | 2.61 |
52-Week Price Change | -48.53% |
50-Day Moving Average | 2.84 |
200-Day Moving Average | 3.16 |
Relative Strength Index (RSI) | 61.37 |
Average Volume (20 Days) | 485.53K |
Income Statement
In the last 12 months, CureVac N.V. had revenue of $53.76M and earned -$260.17M in profits. Earnings per share was $-1.18.
Revenue | 53.76M |
Gross Profit | -70.61M |
Operating Income | -274.21M |
Net Income | -260.17M |
EBITDA | -234.09M |
EBIT | -274.21M |
Earnings Per Share (EPS) | -1.18 |
Balance Sheet
The company has $402.45M in cash and $41.82M in debt, giving a net cash position of $360.63M.
Cash & Cash Equivalents | 402.45M |
Total Debt | 41.82M |
Net Cash | 360.63M |
Retained Earnings | -1.57B |
Total Assets | 854.19M |
Working Capital | 490.36M |
Cash Flow
In the last 12 months, operating cash flow was -$267.89M and capital expenditures -$55.20M, giving a free cash flow of -$323.09M.
Operating Cash Flow | -267.89M |
Capital Expenditures | -55.20M |
Free Cash Flow | -323.09M |
FCF Per Share | -1.47 |
Margins
Gross margin is -131.34%, with operating and profit margins of -510.08% and -483.96%.
Gross Margin | -131.34% |
Operating Margin | -510.08% |
Pretax Margin | -483.59% |
Profit Margin | -483.96% |
EBITDA Margin | -435.45% |
EBIT Margin | -510.08% |
FCF Margin | -601% |
Dividends & Yields
CVAC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -37.46% |
FCF Yield | -45.65% |
Analyst Forecast
The average price target for CVAC is $10, which is 217.5% higher than the current price. The consensus rating is "Hold".
Price Target | $10 |
Price Target Difference | 217.5% |
Analyst Consensus | Hold |
Analyst Count | 3 |
Scores
Altman Z-Score | 2.98 |
Piotroski F-Score | 8 |